PCOS Has a New Name: What 'PMOS' Means and Why It Matters

On May 12, 2026, a paper published in The Lancet and presented at the European Congress of Endocrinology in Prague made it official: the condition we've known as Polycystic Ovary Syndrome (PCOS) is now called Polyendocrine Metabolic Ovarian Syndrome (PMOS).
It's the most extensive disease-renaming process in modern medical history - 11 years of work, 22,000 stakeholders consulted, three global surveys, and a coordinated push by clinicians, researchers, charities, and the patients themselves.
This guide breaks down what the new name actually means, why the change took a decade, and - most importantly - what it changes for the millions of people living with the condition.
What PMOS stands for
Polyendocrine Metabolic Ovarian Syndrome.
Each word does deliberate work:
- Polyendocrine - multiple hormone systems are involved, not just reproductive hormones
- Metabolic - the condition affects insulin sensitivity, weight regulation, and cardiovascular risk
- Ovarian - the ovaries are still a key site of dysfunction, just not the only one
- Syndrome - a collection of related symptoms, not a single disease with one cause
The name is a deliberate signal: this is not, and never was, just a gynecological problem.
Why change a name everyone knew?
The old name was actively harmful. Here's what was wrong with it.
"Polycystic" was misleading
The "cysts" in PCOS are not actually cysts. They're small, immature follicles on the ovaries - and crucially, not everyone with the condition has them. Plenty of people received normal ultrasound results and were told they "didn't have PCOS" despite having every other feature. Plenty more had the cyst-like follicles without any of the metabolic or hormonal symptoms.
The name pointed at the wrong organ and the wrong feature, and it caused real diagnostic damage.
It implied a single, localized problem
PCOS sounded like an ovary problem. In reality, the condition involves the pancreas (insulin resistance), adrenal glands (androgen excess), liver (lipid handling), skin (acne, hirsutism, hair loss), and brain (mood and metabolic regulation). Calling it "ovarian" let clinicians outside gynecology dismiss it as "not their problem."
It contributed to under-diagnosis
The World Health Organization estimates that up to 70% of people with the condition are undiagnosed. When a condition is named after a feature half of patients don't have, that's not a coincidence - it's a consequence.
It carried unnecessary stigma
For decades, the "cyst" terminology has confused patients, partners, and even some clinicians into thinking the condition is a fertility problem first and a health problem second. PMOS reframes it as what it is: a lifelong metabolic and endocrine condition that happens to affect fertility, not the other way around.
What the new name captures
PMOS recognizes the condition as a multisystem disorder with five overlapping domains:
- Endocrine - elevated androgens, irregular gonadotropin pulses, insulin dysregulation
- Metabolic - insulin resistance, increased risk of type 2 diabetes, dyslipidemia, fatty liver
- Reproductive - irregular or absent ovulation, anovulatory cycles, fertility challenges
- Dermatological - acne, hirsutism (excess hair), androgenic hair loss, acanthosis nigricans
- Psychological - significantly elevated rates of anxiety, depression, eating disorders, and body image concerns
Treating any one of these in isolation has been the historical failure. The new name pushes care toward where the evidence has pointed for years: integrated, multidisciplinary management.
What hasn't changed
If you were diagnosed with PCOS, you don't have a new condition. You have the same condition with a more accurate name. Specifically:
- Diagnostic criteria stay the same - the 2023 International Evidence-Based Guideline still applies (irregular cycles + clinical/biochemical hyperandrogenism + polycystic ovarian morphology, with two of three required in adults).
- Treatments don't change - lifestyle, metformin, combined oral contraceptives, anti-androgens, inositol, and fertility treatments where relevant.
- Your medical records don't need to be reissued - clinicians will transition over time. Both names will coexist for years.
What does change is the framing of follow-up care, which is now expected to include metabolic and cardiovascular screening as a default, not an afterthought.
Symptoms to watch for
PMOS affects an estimated 13% of reproductive-age women worldwide - roughly 170 million people. If you have several of the following, especially in combination, it's worth a conversation with your doctor:
Reproductive
- Irregular periods (cycles longer than 35 days, fewer than 8 periods a year)
- Very heavy or very light periods
- Difficulty conceiving
- Skipped periods that aren't explained by pregnancy, breastfeeding, or perimenopause
Hormonal / skin
- Acne that started or worsened in your late teens / 20s, especially along the jawline
- Excess hair growth on the face, chest, abdomen, or thighs
- Thinning hair at the crown or temples (female-pattern hair loss)
- Darkened, velvety skin patches in skin folds (acanthosis nigricans)
Metabolic
- Weight gain - especially around the abdomen - that resists usual interventions
- Strong sugar or carb cravings, particularly in the afternoon
- Difficulty losing weight even with significant effort
- Family history of type 2 diabetes
Other
- Persistent fatigue
- Mood swings, anxiety, or depression beyond what's typical for you
- Sleep disturbances, including a possible link to sleep apnea
You do not need all of these to have PMOS. Most people have a distinctive pattern of two or three categories.
If you suspect you have PMOS
A workup typically includes:
- A detailed history of cycle patterns, weight changes, skin and hair changes, family history
- A pelvic ultrasound - still useful, but no longer the headline feature
- Blood tests - total and free testosterone, DHEA-S, SHBG, LH/FSH, TSH, prolactin, fasting glucose and insulin, HbA1c, lipid panel, AMH
- Screening for related conditions - sleep apnea, depression, fatty liver, endometrial thickness in those with long anovulatory periods
If your first clinician is dismissive, get a second opinion. "Just lose weight" is not a diagnosis. "Come back when you want to get pregnant" is not a management plan. PMOS is a lifelong condition with cardiovascular, metabolic, and mental health implications that deserve attention regardless of fertility plans.
Before your visit, run the free PCOS Symptom Checker - eight questions across cycle, skin, hair, and metabolic signs that score your pattern and surface a clear list of things to mention to a doctor. (Same condition, new name - the checker covers the symptom set ACOG and NIH still use.)
What the renaming process actually involved
The history is worth knowing because it sets a precedent for how medical terminology can evolve from the inside out.
- 2014: First formal calls to rename PCOS at an NIH workshop
- 2017: First international stakeholder survey
- 2023: Second survey alongside the global evidence-based guideline update
- 2025: Third survey with nearly 15,000 stakeholders - patients, clinicians, researchers, charities
- May 2026: Final consensus paper published in The Lancet, new name adopted
The process was led by Helena Teede at Monash University in Australia. Roughly 22,000 people across more than 70 countries contributed input - making this, by patient-involvement metrics, the most participatory disease renaming on record.
What this means for tracking and self-management

A more accurate name should mean more accurate self-monitoring. If you have PMOS - or think you might - the data that actually matters across all five domains:
- Cycle length and variability - irregular patterns are often the first signal
- Period heaviness and duration - long, heavy periods can indicate prolonged anovulation
- Skin and hair changes - acne flares, hair growth, hair loss tracked over time
- Mood and energy - weekly or daily logs surface patterns clinicians often miss
- Weight, sleep, and food cravings - the metabolic side that's easiest to overlook
This is the case Femora's daily logging is built for. Tracking cycle length, flow, mood, symptoms, and notes in one place gives you a year's worth of data to bring to your appointment - turning "I think my cycles are weird" into "here's the median, the standard deviation, and the symptom cluster."
The bigger picture
A name doesn't fix a healthcare system. PMOS will still be under-recognized, under-funded, and under-researched relative to its prevalence - at least for a while. But naming the condition for what it actually is, after a decade of work by the people who live with it, is not a cosmetic change. It's a foundation for better diagnosis, better integrated care, and a clearer message to anyone with the condition: this is real, it is multisystem, and it deserves serious attention.
If you have PMOS, what changed last week is not your body. What changed is the medical world's willingness to describe it accurately.
Track your cycle, symptoms, mood, and notes with Femora - free on iOS and Android. The more data you bring to your appointments, the better your care.
Sources
- PCOS is now called PMOS. The renaming process lasted a decade. - STAT, May 12, 2026
- How the PCOS name change could help more women get diagnosed - The Washington Post, May 16, 2026
- Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care - Endocrine Society, May 2026
- PMOS: The New Name for PCOS - Children's Hospital Colorado, May 2026
- PCOS Renamed PMOS in Landmark Shift Reflecting Metabolic and Endocrine Features - AJMC, May 2026